EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

NAXD Deficiency: Heterogeneous Phenotypes and Positive Response to Niacin Treatment

Najmesadat Seyedkatouli, Liana N Semcesen, Lucia Gallucci, Tim Sikora, Jean-François Conrotte, Mei R M Du, Marat Kasakin, Gezime Seferi, Licia Corona, Martin Jakubec, Brunda Nijagal, Sajel Lala und 22 weitere

Journal of Inherited Metabolic Disease · 2026-07 · 49 (4)

DOI: 10.1002/jimd.70217 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 12.07.2026. Verfasst von Najmesadat Seyedkatouli und 33 weiteren Autor:innen. Beteiligte Einrichtung: Enzymology and Metabolism Group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: Leukoencephalopathies, Niacin. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Government's Operational Infrastructure Support Program, Mito Foundation, Victorian Health and Medical Research Workforce Project, The Victorian Government, The Victorian Department of Jobs, Precincts and Regions, AAMRI and VESKI Vic….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early‐onset progressive encephalopathy with brain edema and/or leukoencephalopathy‐2 (PEBEL2) is a rare autosomal recessive neurometabolic disorder caused by pathogenic variants in NAXD , in which febrile illness or infection triggers rapid clinical deterioration. We describe nine new cases that expand the clinical and molecular spectrum. Four children showed the typical presentation of severe neurological decline following fever or illness and carried variants affecting the enzyme domain. Four cases presented with illness‐triggered cardiac dysfunction associated with variants in the mitochondrial targeting sequence. One case showed severe prenatal neurodegeneration resulting in stillbirth. In two patients, disease onset followed COVID‐19 infection. Functional analysis of five missense variants demonstrated impaired NAXD protein solubility, reduced NADHX dehydratase activity and/or decreased thermostability. Patient fibroblasts confirmed accumulation of damaged cofactors (S‐, R‐ and cyclic NADHX) and reduced NAXD protein levels. Comparative proteomic analysis revealed distinct molecular profiles in atypical cardiac and prenatal cases compared with typical neurological presentations. Four patients received high‐dose niacin (vitamin B3) and survived repeated febrile episodes. These findings support early recognition and suggest that niacin therapy may improve outcomes across the clinical spectrum of PEBEL2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukoencephalopathiesNiacinChildFemaleHumansMalePhenotype

Stichwörter der Autor:innen

NAXDPEBEL2mitochondrianeurodegenerationniacinpaediatric

Substanzen

Niacin

Autor:innen und Institutionen

  • Enzymology and Metabolism Group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, the University of Melbourne, Parkville, Victoria, Australia.
  • Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Metabolomics Australia, Bio21 Institute, the University of Melbourne, Melbourne, Victoria, Australia.
  • Division of Clinical Genetics, Nickelaus Children's Health System, Coral Gables, Florida, USA.
  • Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Pennsylvania, USA.

ORCID-Profile: Marina Szlago, Dung Vu Chi, David R Thorburn, John Christodoulou, Carole L Linster, Nicole J Van Bergen

Förderung

  • Victorian Government's Operational Infrastructure Support Program
  • Mito Foundation
  • Victorian Health and Medical Research Workforce Project, The Victorian Government, The Victorian Department of Jobs, Precincts and Regions, AAMRI and VESKI Vic…
  • Royal Children's Hospital Foundation
  • National Health and Medical Research Council
  • Australian Medical Research Future Fund (MRFF); Genomics Health Futures Mission
  • Luxembourg National Research Fund (Fonds National de la Recherche - FNR)
  • INTER European Joint Programme on Rare Diseases (EJP RD) grant

Zitieren

APA

Seyedkatouli, N., Semcesen, L. N., Gallucci, L., Sikora, T., Conrotte, J. F., Du, M. R. M., Kasakin, M., Seferi, G., Corona, L., Jakubec, M., Nijagal, B., Lala, S., Ganetzky, R. D., Barreto, A. M. R., Szlago, M., Wong, M., Shah, M., Nurse, J., Foulds, N., …, & Van Bergen, N. J. (2026). NAXD Deficiency: Heterogeneous Phenotypes and Positive Response to Niacin Treatment. Journal of Inherited Metabolic Disease, 49(4). https://doi.org/10.1002/jimd.70217

Vancouver

Seyedkatouli N, Semcesen LN, Gallucci L, Sikora T, Conrotte JF, Du MRM, et al. NAXD Deficiency: Heterogeneous Phenotypes and Positive Response to Niacin Treatment. Journal of Inherited Metabolic Disease. 2026;49(4). doi:10.1002/jimd.70217

BibTeX
@article{Seyedkatouli2026,
  author = {Seyedkatouli, Najmesadat and Semcesen, Liana N and Gallucci, Lucia and Sikora, Tim and Conrotte, Jean-François and Du, Mei R M and Kasakin, Marat and Seferi, Gezime and Corona, Licia and Jakubec, Martin and Nijagal, Brunda and Lala, Sajel and Ganetzky, Rebecca D and Barreto, Ana Maria Rodriguez and Szlago, Marina and Wong, Melanie and Shah, Margit and Nurse, James and Foulds, Nicola and Sadagopan, Shankar and Thu, Ha Nguyen and Chi, Dung Vu and Ngoc, Khanh Nguyen and de Silva, Michelle G and Ramialison, Mirana and Rossello, Fernando and MitoMDT Diagnostic Network for Genomics and Omics, MitoMDT Diagnostic Network for Genomics and Omics and Thorburn, David R and Lynch, Matthew and McGrath, Pauline and Stroud, David A and Christodoulou, John and Linster, Carole L and Van Bergen, Nicole J},
  title = {NAXD Deficiency: Heterogeneous Phenotypes and Positive Response to Niacin Treatment},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1002/jimd.70217}
}
Kostenlos starten →